The LWCN Programme Board has a key role in supporting the Clinical Director in making decisions and providing both challenge and approval on issues affecting the progress of the LWCN Programme. The Programme Board ensures a collaborative approach to Lymphoedema service delivery across Wales to sustain an environment that supports equitable Lymphoedema care. The Programme Board meets quarterly, provides assurance to the LWCN Strategy Board of benefits realised and is accountable to Welsh Government.
Membership includes senior managers who have an interest in the LWCN Programme. It is chaired by Adele Cahill, Associate Director, Value Based Health Care, Aneurin Bevan and includes the following representation:
Clinical Director, LWCN
National Lymphoedema Education and Research Lead, LWCN
Programme Management Office, LWCN
Patient Representatives
Finance Delivery Unit
Digital Health and Care Wales
Therapies Representative
Primary Care Representative
Corporate Governance
Health Education Inspectorate Wales
Surgical Materials Testing Laboratory
Transformation Representative
Value Based Health Care
Procurement
Children and Young People
Senior Management Representation 7 Health Boards.